BioLineRx Cash Flow Statement (2021-2025) | BLRX

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -5.03M-6.14M-5.90M-6.13M-5.83M-7.14M-6.70M-8.97M-8.95M-8.14M-11.21M-16.77M-3.33M-3.15M-3.33M6.30M-1.68M-1.54M-1.53M-2.80M
Gains from Investment Securities (Quarter) 4.60M0.29M-0.80M-2.15M-1.25M-0.42M-1.10M-3.65M3.04M7.80M3.12M-2.91M-4.44M-8.40M-0.72M-5.40M-8.31M1.90M-1.13M-1.05M
Non-cash Items (Quarter) 3.96M6.16M4.68M-0.66M0.50M-1.34M-1.29M4.15M13.68M19.13M38.01M-13.41M-25.23M-29.23M-34.65M-7.72M-5.31M-5.08M-6.05M
Change in Working Capital (Quarter) -2.18M0.99M-0.68M-17.97M1.36M
Cash from Operations (Quarter) -6.23M-6.83M-5.01M-5.50M-5.59M-6.29M-8.68M-5.68M-8.02M-9.68M-9.90M4.99M-14.11M-11.33M-9.82M-8.61M-2.59M-0.18M-2.11M-3.20M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter) 0.03M0.70M
Amortization (Quarter) 5.44M-1.80M-0.83M-1.19M4.15M-79.75M-13.41M-11.81M-4.00M20.01M-7.72M2.41M-0.95M-1.04M
Depreciation & Amortization (CF) (Quarter) 0.18M0.18M0.17M0.17M0.17M0.14M0.15M0.19M0.26M0.20M0.22M0.71M0.90M0.48M0.84M1.85M0.17M0.18M0.12M0.06M
Change in Working Capital
Change in Receivables (Quarter) -2.47M-0.35M-0.43M1.14M1.01M1.39M0.08M-0.05M
Change in Inventory (Quarter) -1.35M-0.60M-0.94M-0.74M0.09M0.40M-0.17M0.47M0.67M0.03M
Change in Account Payables (Quarter) -0.50M-0.47M0.18M0.23M0.25M1.42M-1.29M1.50M0.39M-0.11M2.13M3.10M-3.51M-2.12M-0.59M0.71M
Change in Accured Expenses (Quarter) -0.50M-0.47M0.18M-3.51M-2.12M-0.59M-2.51M0.03M-0.57M
Other Working Capital Changes (Quarter) -0.98M-0.24M0.86M0.37M-0.08M-0.61M0.28M-0.24M-0.12M0.12M-0.57M13.52M-3.93M-3.55M-3.22M-2.25M
Investing Activities
Capital Expenditures (Quarter) -0.02M-0.02M0.00M-0.06M-0.02M-0.04M-0.01M-0.06M-0.03M-0.07M-0.00M-0.02M-0.03M-0.03M0.01M
Change in Intangibles (Quarter) -0.01M-0.17M-0.10M-0.06M-0.03M-0.00M
Change in Acquisitions & Divestments (Quarter) -42.00M-16.00M-12.00M-8.00M-7.00M-2.00M-27.00M-8.00M-5.50M-0.51M-7.88M-33.71M16.72M-37.28M-5.79M-12.31M-12.51M-4.21M-7.62M
Cash from Investing Activities (Quarter) -36.26M-6.00M0.04M4.00M5.05M10.03M-14.94M3.86M6.64M11.10M4.10M-20.39M16.69M-8.64M10.18M11.16M-8.18M-3.70M3.67M-0.34M
Financing Activities
Cash from Financing Activities (Quarter) 41.91M14.09M1.57M0.17M-0.94M-0.69M22.72M-0.65M-0.05M-0.13M3.50M11.74M-0.89M23.88M-1.22M-1.11M9.45M1.60M-0.92M-1.25M
Additional items
Exchange Rate Effect (Quarter) -0.20M0.17M-0.01M0.24M-0.06M-0.50M0.01M-0.05M-0.10M-0.25M-0.07M0.19M0.05M0.17M-0.36M0.16M-0.08M-0.27M0.77M0.12M
Change in Cash (Quarter) -0.58M1.26M-3.40M-1.33M-1.48M3.05M-0.90M-2.47M-1.42M1.28M-2.31M-3.66M1.68M3.90M-0.87M1.44M-1.32M-2.28M0.65M-4.79M
Free Cash Flow (Quarter) -6.21M-6.81M-5.02M-5.44M-5.57M-6.25M-8.67M-5.63M-7.98M-9.62M-9.90M5.01M-14.08M-11.30M-9.82M-8.62M-2.59M-0.18M-2.11M-3.20M
Net Cash Flow (Quarter) -0.58M1.26M-3.40M-1.33M-1.48M3.05M-0.90M-2.47M-1.42M1.28M-2.31M-3.66M1.68M3.90M-0.87M1.44M-1.32M-2.28M0.65M-4.79M